Close out 2024 with the Supplements in the Ozempic Age report
| | | | Are you prepared to lead in the rapidly evolving weight loss and blood sugar management markets? With GLP-1 drugs like Ozempic reshaping consumer expectations, staying ahead is no longer optional—it’s essential.
The Supplements in the Ozempic Age is a special-release report written by nutrition industry experts to guide brands through this unprecedented trend. Released just weeks ago, it’s your opportunity to begin 2025 on the cutting edge of innovation and market understanding.
This report delivers comprehensive market data and unmatched consumer insights through 67 survey charts, revealing how consumers at every stage of GLP-1 use—whether they’re considering, currently taking, or have previously used these drugs—view the role of supplements. From standalone solutions to complementary options alongside GLP-1 drugs, these insights uncover new opportunities to position your brand for growth.
Close out 2024 with the data you need to dominate in 2025 with the Supplements in the Ozempic Age special report. |
|
|
|
| Join us on January 8th for NBJ's first live webinar of 2025. Market Research Analyst Erika Craft and Editor-in-Chief Rick Polito will dive into the evolving weight loss market, from market sizing insights to how supplement brands can support GLP-1 consumers at every stage of their weight loss journey. Bring your questions to be answered live or submit your questions in advance before the webinar. | | Event Details |
|
|
|
|
